A. C. Van Loenen

1.3k citations
40 papers · 958 indexed · h-index 16
Topics
Multiple Sclerosis Research Studies (3 papers)Chemotherapy-induced organ toxicity mitigation (3 papers)Nausea and vomiting management (2 papers)
Partner nations
NetherlandsItalyBelgium

In The Last Decade

A. C. Van Loenen

33 papers receiving 895 citations

Peers

A. C. Van Loenen
Comparison fields: 5 of 106
  • Pharmacology 307
  • Pathology and Forensic Medicine 245
  • Physiology 167
  • Anesthesiology and Pain Medicine 147
  • Immunology 147
Replace John T. Sullivan with:
John T. Sullivan United States
C. Mclean Australia
Sahar Shekoohi United States
Yasuo Ito Japan
Rong Jiang China
Laura Bossi Italy
Taotao Liu China
Eigill F. Hvidberg Denmark
Lennart Nässberger Sweden
Morteza Jafarinia Iran
A. C. Van Loenen relative to John T. Sullivan United States John T. Sullivan's profile →
Citations per field
00.5×11.3×
John T. Sullivan · 1×
Citations per year

Countries citing papers authored by A. C. Van Loenen

Since Specialization
Citations

This map shows the geographic impact of A. C. Van Loenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. C. Van Loenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. C. Van Loenen more than expected).

Fields of papers citing papers by A. C. Van Loenen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. C. Van Loenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. C. Van Loenen. The network helps show where A. C. Van Loenen may publish in the future.

Co-authorship network of co-authors of A. C. Van Loenen

This figure shows the co-authorship network connecting the top 25 collaborators of A. C. Van Loenen. A scholar is included among the top collaborators of A. C. Van Loenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. C. Van Loenen. A. C. Van Loenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 18
2 57
3
Ziekte van Alzheimer: nieuwe inzichten in de farma-cotherapie
0
4 143
5 2
6 47
7 68
8 45
9 3
10 69
11 16
12 1
13 17
14 69
15 82
16
Comparison of two different high doses of metoclopramide in the prevention of chemotherapy-induced emesis.
1
17 11
18 12
19 11
20 26

About A. C. Van Loenen

A. C. Van Loenen is a scholar working on Applied Microbiology and Biotechnology, Pharmacology and Dermatology, having authored 40 papers that have together received 958 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Nausea and vomiting management (2 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (147 citations), Pharmacology (307 citations) and Pathology and Forensic Medicine (245 citations). A. C. Van Loenen has collaborated with scholars based in Netherlands, Italy and Belgium. Frequent co-authors include Pim N.J. Langendijk, F.W. Bertelsmann, D. de Hoop, C. Nieboer, CH Polman, W. W. A. Zuurmond, J. J. de Lange, Chris H. Polman, J.C. Koetsier and H.A.M. van Diemen. Their work appears in journals such as Journal of Clinical Oncology, Neurology and Journal of the American Academy of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026